LASIX furosemide 40mg/4mL injection ampoule

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Buy It Now

Active ingredient:

furosemide sodium, Quantity: 10.664 mg/mL (Equivalent: furosemide, Qty 10 mg/mL)

Available from:

Sanofi-Aventis Australia Pty Ltd

Pharmaceutical form:

Injection, solution

Composition:

Excipient Ingredients: sodium hydroxide; sodium chloride; water for injections

Administration route:

Intravenous, Intramuscular

Units in package:

5 x 4mL ampoules

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Oedema: Lasix is indicated in adults, infants and children for the treatment of oedema associated with congestive heart failure, cirrhosis of the liver and renal disease including nephrotic syndrome. Lasix is particularly useful when an agent with greater diuretic potential than that of those commonly employed is desired. Parenteral therapy should be reserved for patients unable to take oral medication, or for patients in emergency clinical situations. Lasix injection is also indicated as adjunctive therapy in acute pulmonary and cerebral oedema where intense and rapid onset of diuresis is desired. If gastrointestinal absorption is impaired or oral medication is not practical for any reason, Lasix is indicated by the intravenous route. Parenteral use should be replaced with oral Lasix as soon as practical.

Product summary:

Visual Identification: Clear, colourless liquid, free of particulate matter.; Container Type: Ampoule; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2000-11-15

Patient Information leaflet

                                LASIX® AND LASIX® HIGH DOSE
1
LASIX
®
, LASIX
® M AND
LASIX
® HIGH DOSE
_Furosemide (Frusemide) _
CONSUMER MEDICINE INFORMATION (CMI)
WHAT IS IN THIS LEAFLET
This leaflet answers some common
questions about Lasix oral medicines
(tablets, oral solution) and injections.
It does not contain all the available
information. It does not take the
place of talking to your doctor or
pharmacist.
All medicines have risks and
benefits. Your doctor has weighed
the risks of you taking this medicine
against the benefits they expect it
will have for you.
IF YOU HAVE ANY CONCERNS ABOUT
TAKING THIS MEDICINE, ASK YOUR
DOCTOR OR PHARMACIST.
KEEP THIS LEAFLET WITH THE MEDICINE.
You may need to read it again.
WHAT LASIX IS USED FOR
Lasix contains furosemide
(frusemide), which belongs to a
family of drugs called diuretics. A
diuretic helps reduce the amount of
excess fluid in the body by increasing
the amount of urine produced.
Lasix is used to treat swelling of the
ankles, feet, legs or even the brain or
lungs. This swelling is called oedema
and can occur in some heart, lung,
liver or kidney conditions.
Lasix may be used in some patients
with more serious kidney problems
who may have some fluid retention.
Lasix may also be used to lower high
blood pressure (which is also called
hypertension).
Everyone has blood pressure. This
pressure helps move your blood
around your body. Your blood
pressure may vary at different times
of the day, depending on how busy or
worried you are. You have
hypertension (high blood pressure)
when your blood pressure stays
higher than is needed, even when you
are calm and relaxed.
If high blood pressure is not treated it
can lead to serious health problems,
including stroke, heart disease and
kidney failure.
Lasix may be taken alone or in
combination with other medicines to
treat your condition.
Your doctor may have prescribed
Lasix for another purpose.
ASK YOUR DOCTOR IF YOU HAVE ANY
QUESTIONS ABOUT WHY IT HAS BEEN
PRESCRIBED FOR YOU.
This medicine is only available with
a doctor's prescription.
This medi
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                lasix-ccdsv12-piv25-31jan22
1
AUSTRALIAN PRODUCT INFORMATION – LASIX (FUROSEMIDE
(FRUSEMIDE)) TABLETS AND ORAL SOLUTION AND LASIX
(FUROSEMIDE (FRUSEMIDE) SODIUM) INJECTIONS
1
NAME OF THE MEDICINE
For Oral Solution and Tablets: Furosemide (Frusemide)
For Injections: Furosemide (Frusemide) sodium
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Lasix M Tablets contain 20 mg furosemide (frusemide).
Lasix Tablets contain 40 mg furosemide (frusemide).
Lasix Oral Solution contains 10 mg/mL furosemide (frusemide).
Lasix 20 mg/2 mL injection: each 2 mL contains 20 mg furosemide
(frusemide) as
furosemide (frusemide) sodium. Contains 0.16 mmol/mL of sodium.
Lasix 40 mg/4 mL injection: each 4 mL contains 40 mg furosemide
(frusemide) as
furosemide (frusemide) sodium. Contains 0.16 mmol/mL of sodium.
EXCIPIENTS WITH KNOWN EFFECT
Lasix 20 mg and 40 mg tablets contain sugars as lactose.
Lasix Oral Solution contains benzoates, sorbitol and alcohol.
For the full list of excipients, see Section 6.1 List of excipients.
3
PHARMACEUTICAL FORM
Lasix M Tablets 20 mg tablets are white, round flat-faced tablets with
bevelled edge
debossed with “DLF” on one side and plain on the other face.
Lasix 40 mg tablets are yellow, round, flat-faced tablets with
bevelled edge debossed with
“LASIX ” above the score line and “40” below the score line on
one side, and the Hoechst
logo on the other side.
Lasix Oral Solution is a clear yellow liquid.
Lasix Injections are clear colourless solutions, practically free of
visible particles.
lasix-ccdsv12-piv25-31jan22
2
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
OEDEMA
Lasix is indicated in adults, infants and children for the treatment
of oedema associated with
congestive heart failure, cirrhosis of the liver and renal disease
including the nephrotic
syndrome. Lasix is particularly useful when an agent with greater
diuretic potential than that
of those commonly employed is desired. Parenteral therapy should be
reserved for patients
unable to take oral medication or for patients in emergency
                                
                                Read the complete document